Physician profile
Lauro Y Roberto
NPI 1194878512
$10,494.09
in general payments reported to CMS, 2019-2025
31 companies · $1,352 in 2025
The $1,352 reported for 2025 was more than what 90% of Pediatric Pulmonology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,573 · 2020: $596 · 2021: $1,043 · 2022: $1,748 · 2023: $2,017 · 2024: $1,165 · 2025: $1,352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,363 · Education: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,363.09 |
| Education | $170.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $1,477.49 | 2019-2025 | Dupixent |
| Abbvie INC. | $1,376.33 | 2019-2025 | Creon, Linzess |
| Astrazeneca Pharmaceuticals Lp | $985.13 | 2019-2025 | Fasenra, Tezspire |
| Chiesi USA, INC. | $771.18 | 2019-2023 | Bronchitol, Pertzye |
| Baxter Healthcare | $612.53 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Novartis Pharmaceuticals Corporation | $578.00 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $549.00 | 2019-2025 | Trikafta |
| Digestive Care, INC. | $536.19 | 2023-2025 | Pertzye |
| Electromed, INC. | $499.18 | 2019-2025 | Smartvest |
| Advanced Respiratory, INC | $460.57 | 2019-2021 | |
| Philips North America LLC | $404.47 | 2019-2025 | Vest Therapy Und, (8874) Incourage, (Ak6) Vest Therapy |
| Glaxosmithkline, LLC. | $355.06 | 2019-2024 | Nucala |
| Genentech USA, INC. | $231.06 | 2019-2023 | Xolair |
| Nestle Healthcare Nutrition INC. | $182.79 | 2022-2023 | |
| Mylan Specialty L.P. | $171.86 | 2019-2023 | Tobi Podhaler |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $163.30 | 2021-2025 | Tezspire |
| Inspire Medical Systems, INC. | $153.06 | 2023 | Inspire |
| Allergan, INC. | $132.67 | 2019 | |
| Genzyme Corporation | $119.97 | 2019-2025 | |
| Pharming Healthcare, INC. | $118.76 | 2022-2025 | Ruconest |
| Sobi, INC | $118.05 | 2019-2020 | |
| Gilead Sciences, INC. | $100.46 | 2019-2021 | |
| Aimmune Therapeutics, INC. | $75.99 | 2024-2025 | Zenpep |
| Takeda Pharmaceuticals U.S.A., INC. | $70.18 | 2023 | Elaprase |
| Fisher & Paykel Healthcare INC | $66.65 | 2019-2025 | Fisher & Paykel Healthcare |
| Alcresta Therapeutics, INC. | $46.00 | 2019-2025 | Relizorb |
| Teva Pharmaceuticals USA, INC. | $37.41 | 2019 | |
| Monaghan Medical Corporation | $34.43 | 2022-2025 | Aeroeclipse |
| Ars Pharmaceuticals Operations, INC. | $25.97 | 2025 | Neffy |
| Vivus LLC | $23.19 | 2022 | |
| Resmed Corp | $17.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauro Roberto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.